Login / Signup

Clinical and Safety Outcomes Associated with Extended Treatment of Venous Thromboembolism: A Network Meta-Analysis.

Zhiqiang LiuJiang-Shan TanYuanrui DengLu HuaTingting Guo
Published in: Journal of cardiovascular development and disease (2022)
There existed no statistically significant differences in recurrence between NOACs and standard-intensity warfarin, and NOACs were associated with a lower risk of bleeding events. Edoxaban effectively prevented VTE recurrence and major bleeding, and apixaban was the best anticoagulant for controlling bleeding events.
Keyphrases
  • venous thromboembolism
  • atrial fibrillation
  • direct oral anticoagulants
  • oral anticoagulants
  • free survival
  • type diabetes
  • replacement therapy